RecruitingNCT06007261

Validation of Rapid On-site Diagnostics in Early Stage Lung Cancer Sampling With a Higher Harmonic Generation Microscope

Validation and Added Clinical Value of Rapid On-site Diagnostics in Early Stage Lung Cancer Sampling With a Higher Harmonic Generation Microscope


Sponsor

Radboud University Medical Center

Enrollment

250 participants

Start Date

Jan 19, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The aim of this study is to verify a new microscopic technique in diagnosing patients suspected of lung cancer. Patients will undergo navigational bronchoscopy or surgical resection as a part of standard of care. Biopsies taken during this procedure will be imaged for a few minutes with a higher harmonic generation (HHG) microscope, after which the material is taken to the pathology department for histopathology assessment, which is currently the golden standard for diagnosis.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • ASA physical status 1-3.
  • Age 18 years or older.
  • A pulmonary lesion with an indication for diagnostic or therapeutic evaluation following current clinical guidelines and/or as decided by multi-disciplinary team consultation.

Exclusion Criteria4

  • Bleeding disorders.
  • Less than 18 years old.
  • Inability to consent.
  • Unfit for navigation bronchoscopy and/or unfit for surgical resection as per guideline recommended care and multi-disciplinary tumor board decision making.

Locations(1)

Radboudumc

Nijmegen, Gelderland, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06007261


Related Trials